Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
Titel:
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
Auteur:
Izikson, Ruvim Brune, Daniel Bolduc, Jean-Sébastien Bourron, Pierre Fournier, Marion Moore, Tamala Mallett Pandey, Aseem Perez, Lucia Sater, Nessryne Shrestha, Anju Wague, Sophie Samson, Sandrine I